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Peroxisomes contain enzymes catalyzing the &oxidation of fatty acids, which have been purified and 
partially characterized. Hypolipidemic drugs, including clofibrate, cause a marked proliferation of 
peroxisomes and a striking increase in the activity of their P-oxidation system. We have compared by 
sodium dodecyl sulfate-polyacrylamide gel electrophoresis the polypeptide patterns of normal and 
clofibrate-induced peroxisomes and the purified &oxidation enzymes. The data allow a tentative 
identification of the &oxidation enzymes among the peroxisomal polypeptides; these enzymes constitute 
only a small part of the protein of normal peroxisomes. A subset of peroxisomal polypeptides, including 
the &oxidation enzymes, is preferentially increased by clofibrate. 
Peroxisome composition Hypolipidemic drugs P-Oxidation enzyme 
SDS-PAGE 
Organelle biogenesis 
1. INTRODUCTION 
Peroxisomes catalyze the &oxidation of fatty 
acids in rat liver [ 1,2]. The individual enzymes in 
this spiral reaction pathway have been purified and 
partially characterized [3-61; their properties dif- 
fer from the corresponding mitochondrial fl-oxida- 
tion enzymes. In particular, the second and third 
enzymes (enoyl-CoA hydratase and fl-hydroxyacyl- 
CoA dehydrogenase) form a bifunctional protein 
[3]. Highly purified peroxisomes have been ana- 
lyzed by SDS-PAGE [7] and by two-dimensional 
mapping and found to contain at least 35 polypep- 
tides (in preparation). 
peroxisomal polypeptides is altered by clofibrate 
treatment: some, but not all, polypeptides are 
increased in abundance as shown by one and two- 
dimensional gel analyses (unpublished). Here, we 
compare by SDS-PAGE the purified &oxidation 
enzymes and the total peroxisomal proteins of nor- 
mal and clofibrate-treated rats. The results allow a 
tentative identification of the P-oxidation enzymes, 
and indicate that they are several of the peroxi- 
somal polypeptides most noticeably increased by 
clofibrate. 
2. EXPERIMENTAL 
Clofibrate, a hypolipidemic drug, causes peroxi- Peroxisome were purified from normal female 
some proliferation [8,9] and a lo-fold increase in Sprague-Dawley rats by differential and isopycnic 
the activity of peroxisomal P-oxidation [l]. The bi- centrifugation in sucrose according to [ 121. Peroxi- 
functional protein has been shown to be identical some were purified from clofibrate-treated male 
[ 101, as suggested [3], with a peroxisomal prolifera- Fisher F-344 rats (0.5% clofibrate in the chow for 
tion associated polypeptide Ill]. The pattern of 2 weeks) by differential centrifugation in sucrose 
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[12] followed by isopycnic centrifugation in a 
metrizamide gradient [ 131. Triton WR-1339 pre- 
treatment was omitted because peroxisomes and 
lysosomes are well-separated in metrizamide gra- 
dients without it [13]. The peroxisomes from nor- 
mal and clofibrate-treated rats were 85-95% pure 
according to marker enzyme analyses (see [7] for 
method). Control experiments have shown that 
neither sex nor strain differences are responsible 
for the changes to be reported below. Acyl-CoA 
oxidase [4], the bifunctional hydratase-dehydro- 
genase [3] and the thiolase [6] were purified as des- 
cribed from rats treated with di(2_ethylhexyl)phtha- 
late to increase peroxisomal &oxidation [ 141. The 
bifunctional protein was also purified from clofi- 
brate-fed rats by a modified procedure to be des- 
cribed elsewhere. SDS-PAGE was done as before 
using 7- 15 % acrylamide gradient gels [ 151. 
3. RESULTS 
Clofibrate treatment causes striking changes in 
the SDS-PAGE pattern of polypeptides of highly 
purified peroxisomes (cf. lanes 2,3 in fig. 1 which 
have equal amounts of protein). A number of Co- 
omassie blue-stained bands increase in abundance 
while others decrease. 
The bifunctional protein (enoyl-CoA hydratase 
and P-hydroxyacyl-CoA dehydrogenase, HD) 
(lanes 4,5) comigrates with a polypeptide that is 
well-stained in normal peroxisomes (lane 3) and 
which increases greatly after clofibrate treatment 
(lanes 2,6). 
Thiolase (lane 7) comigrates with a band of 
moderate intensity in clofibrate-induced peroxi- 
somes (lane 6). No band can be seen at this position 
in normal peroxisomes in this experiment (lane 8). 
The band in lane 8 marked with a dot migrated 
significantly faster than did thiolase. In another, 
more heavily stained gel (fig. 2), a faint band with 
the mobility of thiolase was observed in normal 
peroxisomes (+). Fig. 2 also reveals that a minor 
component of the purified thiolase preparation 
likewise comigrates with a clofibrate-induced per- 
oxisomal polypeptide (D ). 
The purified acyl-CoA oxidase preparation (fig. 
1, lane 9) contains the components A,B,C des- 
cribed in [4] as well as some larger polypeptides 
presumed to be contaminants. The middle oxidase 
component B comigrates with a Coomassie blue- 
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Fig. 1. SDS-PAGE analyses: Normal peroxisomes (nP, 
lane 3 (30 pg) and lanes 8 and 11 (50 pg)). Peroxisomes 
from clofibrate-treated rats (cP, lane 2 (30 ag) and lanes 
6 and 10 (15 ,ug)). Purified hydratase-dehydrogenase 
bifunctional protein (HD, 2 pg, lane 4 di(2-ethyl- 
hexyl)phthalate-induced; lane 5 clofibrate-induced). 
Purified thiolase (lane 7, 2,ug). Purified acyl-CoA ox- 
idase (lane 9, 4pg). Molecular mass standards (lanes 
1,12): rabbit muscle phosphorylase b (97400), bovine 
serum albumin (68000), ovalbumin (45000), bovine 
erythrocyte carbonic anhydrase (29000), bovine pan- 
creas trypsinogen (24000), soybean trypsin inhibitor 
(21500), bovine &lactoglobulin (18400), egg white 
lysozyme (14300), and bovine lung trypsin inhibitor 
(aprotinin) (6500). 
stained polypeptide in normal peroxisomes (lane 8) 
and in clofibrate-treated peroxisomes (lane 10). 
When equal amounts of protein are loaded (lanes 
2,3), there is clearly much more of this oxidase 
band after clofibrate treatment. 
The large oxidase component A comigrates with 
a polypeptide present in peroxisomes of clofibrate- 
treated rats (lane 10) and with what appears to be 
the lower band in a not fully resolved doublet in 
Volume 150, number 2 FEBS LETTERS December 1982 
Thio- 
nP lose cP 
I2 3 
Fig. 2. Thiolase region of SDS gel: (1) normal peroxi- 
somes; (2) purified thiolase; (3) peroxisomes from a 
clofibrate-treated rat. 
normal peroxisomes (lane 8). This polypeptide’s 
abundance is elevated in peroxisomes after clofi- 
brate treatment (cf. lanes 2,3). The small oxidase 
component C has no visible counterpart in either 
peroxisome preparation and is noticeably fuzzy in 
appearance. 
Because mobilities in SDS-PAGE vary slightly, 
depending on protein load and salt concentrations, 
we prepared mixtures of the purified enzymes and 
the purified peroxisomes, and subjected these mix- 
tures to SDS-PAGE analysis. The results (fig. 3) 
confirm the conclusions drawn from fig. 1,2. 
4. DISCUSSION 
Based on these results, we tentatively identify the 
&oxidation enzymes with those peroxisomal poly- 
peptides with which they comigrate in SDS-PAGE. 
The identification is strengthened by the fact that 
the Coomassie blue staining intensity of each of 
these polypeptides increases strikingly after clofi- 
brate treatment, which is known to cause large in- 
creases in the peroxisomal &oxidation enzyme acti- 
vities [ 1,2]. Other hypolipidemic drugs also increase 
peroxisomal P-oxidation enzyme activities [ 16-201, 
as does the plasticizer, di(2-ethylhexyl)phthalate 
1141. 
Some uncertainty remains concerning the acyl- 
CoA oxidase, whose small component C is not 
detected in peroxisomes in these experiments. 
Component B is found in normal peroxisomes and 
is induced by clofibrate. The significance of the 
large component A has been questioned [5], where 
a purified enzyme of high specific activity was pre- 
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Fig. 3. SDS-PAGE analyses of mixtures of normal 
peroxisomes and purified,&oxidation enzymes. Abbrevi- 
ationxp, peroxisomes (50 ,ug); HD, hydratase-dehydro- 
genase (2 pg); AOx, acyl-CoA oxidase (2 pg); Th, thio- 
lase (2 pg); M, molecular mass standards as in fig. 1. 
pared that contained little of the large component. 
However, in [4] the amino acid composition of A 
was close to the sum of B + C, and suggested that 
they are related by proteolysis in vivo. Further 
work is required to resolve these questions. 
These results indicate that a subset of peroxi- 
somal proteins, including the&oxidation enzymes, 
is selectively elevated by clofibrate. Other peroxi- 
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somal polypeptides decrease in abundance or are 
unaffected. 
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